Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Toronto

$72,000.00

Molecular Regulation of Alternative Splicing by Nuclear Receptors and Coregulators

EF 2024-25

Résumé
The nuclear hormone receptors comprise a superfamily of ligand activated transcription factors that regulate diverse physiological processes by coordinating patterns of gene expression. Transcriptional activation by a nuclear hormone receptor (NR) depends strongly on its interactions with coactivators and corepressors that either directly or indirectly modify the surrounding chromatin configuration to allow recruitment of basal transcriptional machinery. My laboratory is studying the molecular mechanisms contributing to changes in alternative splicing in response to NR hormone signaling. We recently discovered that the glucocorticoid receptor (GR) ligand Dexamethasone (Dex) can alter genome-wide patterns of alternative splicing (in addition to gene expression) in neuronal N2a cells within 4 hours of administration. Intriguingly, genes whose levels of mRNA expression were altered by Dex were largely distinct from those whose alternative splicing (AS) was affected. Thus, AS represents a new layer of gene regulation not previously appreciated for nuclear receptors. Recently, we discovered a new NR coregulator called arginine and glutamate rich 1 (ARGLU1) that plays a role in coactivating transcription as well as modulating AS, both basally and in response to glucocorticoid signaling. Using a proteomics approach, ARGLU1 was shown to interact primarily with RNA splicing factors. Interestingly, we also found that ARGLU1 associated with RBM39 (a member of the U2AF65 family that was previously shown to play a role in steroid-hormone mediated transcription and AS) and JMJD6 (Jumanji domain containing 6), a lysyl hydroxylase and arginine demethylase implicated in chromatin remodeling and AS. Prior studies found that JMJD6 can post-translationally modify splicing factors and impact their function. We will use a variety of gain and loss of function models incorporating the use of neural cells and in vivo inducible neuron-specific ARGLU1 knockout mice to analyze changes in gene expression/AS in response to GC treatment by RNAseq and correlate these to behavioural measures. To directly assess the genome-wide set of RNAs bound to ARGLU1 we will perform HITS-CLIP and compare the identity of the bound RNAs with those shown to be alternatively spliced and transcriptionally altered from RNAseq. We will use biochemical, molecular and proteomic methods to assess the importance of the interaction of ARGLU1 and GR with the chromatin modifier JMJD6 for mediating each of its distinct functions and gain a better understanding of how GR is contributing to AS. The study of RNA binding proteins has yielded significant progress in our understanding of the "splicing code", however, relatively little is known about how hormone-dependent AS is controlled in cells or tissues. This research program will examine the molecular mechanisms by which members of the nuclear receptor superfamily, including GR, help promote transcriptional diversity by coordinating ligand-dependent AS.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2020-07212
Name nom
Cummins, Carolyn
Department département
Pharmacy, Leslie Dan Faculty of - Pharmacy, Leslie Dan Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Molecular Regulation of Alternative Splicing by Nuclear Receptors and Coregulators
Keywords
transcription factor; nuclear receptor; rna splicing; alternative splicing; hormone; rbm39; glucocorticoid; jmjd6; gr; arglu1
Application summary
The nuclear hormone receptors comprise a superfamily of ligand activated transcription factors that regulate diverse physiological processes by coordinating patterns of gene expression. Transcriptional activation by a nuclear hormone receptor (NR) depends strongly on its interactions with coactivators and corepressors that either directly or indirectly modify the surrounding chromatin configuration to allow recruitment of basal transcriptional machinery. My laboratory is studying the molecular mechanisms contributing to changes in alternative splicing in response to NR hormone signaling. We recently discovered that the glucocorticoid receptor (GR) ligand Dexamethasone (Dex) can alter genome-wide patterns of alternative splicing (in addition to gene expression) in neuronal N2a cells within 4 hours of administration. Intriguingly, genes whose levels of mRNA expression were altered by Dex were largely distinct from those whose alternative splicing (AS) was affected. Thus, AS represents a new layer of gene regulation not previously appreciated for nuclear receptors. Recently, we discovered a new NR coregulator called arginine and glutamate rich 1 (ARGLU1) that plays a role in coactivating transcription as well as modulating AS, both basally and in response to glucocorticoid signaling. Using a proteomics approach, ARGLU1 was shown to interact primarily with RNA splicing factors. Interestingly, we also found that ARGLU1 associated with RBM39 (a member of the U2AF65 family that was previously shown to play a role in steroid-hormone mediated transcription and AS) and JMJD6 (Jumanji domain containing 6), a lysyl hydroxylase and arginine demethylase implicated in chromatin remodeling and AS. Prior studies found that JMJD6 can post-translationally modify splicing factors and impact their function. We will use a variety of gain and loss of function models incorporating the use of neural cells and in vivo inducible neuron-specific ARGLU1 knockout mice to analyze changes in gene expression/AS in response to GC treatment by RNAseq and correlate these to behavioural measures. To directly assess the genome-wide set of RNAs bound to ARGLU1 we will perform HITS-CLIP and compare the identity of the bound RNAs with those shown to be alternatively spliced and transcriptionally altered from RNAseq. We will use biochemical, molecular and proteomic methods to assess the importance of the interaction of ARGLU1 and GR with the chromatin modifier JMJD6 for mediating each of its distinct functions and gain a better understanding of how GR is contributing to AS. The study of RNA binding proteins has yielded significant progress in our understanding of the "splicing code", however, relatively little is known about how hormone-dependent AS is controlled in cells or tissues. This research program will examine the molecular mechanisms by which members of the nuclear receptor superfamily, including GR, help promote transcriptional diversity by coordinating ligand-dependent AS.